PL1843746T3 - Formulacje analogów somatostatyny - Google Patents

Formulacje analogów somatostatyny

Info

Publication number: PL1843746T3
Authority: PL; Poland
Prior art keywords: somatostatin analogue; analogue formulations; formulations; somatostatin; analogue
Prior art date: 2005-01-14

Application number

PL05818366T

Other languages

English (en)

Inventor

Fredrik Joabsson

Markus Johnsson

Andreas Norlin

Fredrik Tiberg

Original Assignee

Camurus Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-14

Filing date

2005-12-09

Publication date

2011-09-30

2005-01-14 Priority claimed from GB0500807A external-priority patent/GB0500807D0/en

2005-04-18 Priority claimed from GB0507811A external-priority patent/GB0507811D0/en

2005-06-06 Priority claimed from PCT/GB2005/002217 external-priority patent/WO2005117830A1/en

2005-09-15 Priority claimed from GB0518878A external-priority patent/GB0518878D0/en

2005-12-09 Application filed by Camurus Ab filed Critical Camurus Ab

2011-09-30 Publication of PL1843746T3 publication Critical patent/PL1843746T3/pl

Links

238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229940075620 somatostatin analogue Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dispersion Chemistry (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Hematology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

PL05818366T 2005-01-14 2005-12-09 Formulacje analogów somatostatyny PL1843746T3 (pl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB0500807A GB0500807D0 (en)	2005-01-14	2005-01-14	Formulation
GB0507811A GB0507811D0 (en)	2005-04-18	2005-04-18	Formulation
PCT/GB2005/002217 WO2005117830A1 (en)	2004-06-04	2005-06-06	Liquid depot formulations
GB0518878A GB0518878D0 (en)	2005-09-15	2005-09-15	Formulations
PCT/GB2005/004748 WO2006075124A1 (en)	2005-01-14	2005-12-09	Somatostatin analogue formulations
EP05818366A EP1843746B1 (en)	2005-01-14	2005-12-09	Somatostatin analogue formulations

Publications (1)

Publication Number	Publication Date
PL1843746T3 true PL1843746T3 (pl)	2011-09-30

Family

ID=35986077

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05818366T PL1843746T3 (pl)	2005-01-14	2005-12-09	Formulacje analogów somatostatyny

Country Status (7)

Country	Link
EP (1)	EP1843746B1 (pl)
JP (1)	JP5171262B2 (pl)
KR (1)	KR100983746B1 (pl)
AU (1)	AU2005324794C1 (pl)
CA (1)	CA2594711C (pl)
PL (1)	PL1843746T3 (pl)
WO (1)	WO2006075124A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1845942T1 (sl)	2005-01-14	2014-06-30	Camurus Ab	Gnrh analogne formulacije
US8871712B2 (en)	2005-01-14	2014-10-28	Camurus Ab	Somatostatin analogue formulations
US9649382B2 (en)	2005-01-14	2017-05-16	Camurus Ab	Topical bioadhesive formulations
KR101245022B1 (ko)	2005-01-21	2013-03-19	카무러스 에이비	약제학적 지질 조성물
DK1888031T3 (da)	2005-06-06	2013-02-18	Camurus Ab	GLP-1-analogformuleringer
AU2012202338B2 (en) *	2007-06-15	2015-07-09	Camurus Ab	Peptide slow-release formulations
AU2015227534B2 (en) *	2007-06-15	2017-02-23	Camurus Ab	Peptide slow-release formulations
GB0711656D0 (en) *	2007-06-15	2007-07-25	Camurus Ab	Formulations
GB0716385D0 (en)	2007-08-22	2007-10-03	Camurus Ab	Formulations
EP2052716B1 (en) *	2007-10-24	2014-12-31	Camurus AB	Controlled release formulations
KR100998175B1 (ko)	2008-05-30	2010-12-03	애니젠 주식회사	소마토스타틴의 제조방법
GB0815435D0 (en)	2008-08-22	2008-10-01	Camurus Ab	Formulations
WO2010105685A1 (en) *	2009-03-19	2010-09-23	Universite Pierre Et Marie Curie	Peptides for inhibiting igf-1
PE20141484A1 (es) *	2011-05-25	2014-10-31	Camurus Ab	Formulaciones peptidicas de liberacion controlada
KR101494594B1 (ko)	2011-08-30	2015-02-23	주식회사 종근당	약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
BR112014013693B1 (pt) *	2011-12-05	2023-01-31	Camurus Ab	Pré-formulação, e, uso de uma pré-formulação
TW201336526A (zh) *	2012-01-31	2013-09-16	參天製藥股份有限公司	非水性液體組成物
ES2834318T3 (es) *	2012-05-25	2021-06-17	Camurus Ab	Formulaciones de agonistas de receptores de la somatostatina
KR101586789B1 (ko)	2012-12-28	2016-01-19	주식회사 종근당	양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko)	2012-12-28	2016-01-19	주식회사 종근당	ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko)	2012-12-28	2016-01-19	주식회사 종근당	음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP2823808A1 (en) *	2013-07-09	2015-01-14	Ipsen Pharma S.A.S.	Pharmaceutical composition for a sustained release of lanreotide
AU2017336199B2 (en) *	2016-09-27	2020-08-20	Camurus Ab	Mixtures and formulations comprising an alkyl ammonium EDTA salt
EP3421485A1 (en)	2017-06-30	2019-01-02	Université de Strasbourg	Peptides for treatment and prevention of hyperglycaemia
EP3437651A1 (en)	2017-08-03	2019-02-06	Université de Strasbourg	Peptides for treatment and prevention of nonalcoholic fatty liver disease
CN111432829B (zh)	2017-12-14	2023-07-14	斯特拉斯堡大学	用于治疗和预防非酒精性脂肪肝病和纤维化的肽
DK3897697T5 (da)	2018-12-21	2024-08-05	Univ Strasbourg	Peptider til behandling og forebyggelse af diabetes og forbundne lidelser
JP2021059680A (ja) *	2019-10-08	2021-04-15	花王株式会社	液晶組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0643620B1 (en) *	1991-10-04	1999-07-21	Gs Development Ab	Particles, method of preparing said particles and uses thereof
WO1993006921A1 (en) *	1991-10-04	1993-04-15	Gs Biochem Ab	Particles, method of preparing said particles and uses thereof
SE518578C2 (sv) *	1994-06-15	2002-10-29	Gs Dev Ab	Lipidbaserad komposition
JPH11513393A (ja) *	1995-10-12	1999-11-16	ジーエスディベロップメントエービー	皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物
CA2286052A1 (en) *	1997-04-17	1998-10-29	Lise Sylvest Nielsen	A novel bioadhesive drug delivery system based on liquid crystals
BE1011899A6 (fr) *	1998-04-30	2000-02-01	Ucb Sa	Compositions pharmaceutiques gelifiables utilisables.
EP1682091B1 (en) *	2003-11-07	2017-03-29	Camurus Ab	Compositions of lipids and cationic peptides
CA2554052C (en) *	2004-01-23	2013-10-22	Camurus Ab	Ternary non-lamellar lipid compositions of structure forming amphiphile, structure swelling amphiphile and dispersion stabilising amphiphile

2005
- 2005-12-09 AU AU2005324794A patent/AU2005324794C1/en not_active Expired
- 2005-12-09 PL PL05818366T patent/PL1843746T3/pl unknown
- 2005-12-09 CA CA2594711A patent/CA2594711C/en not_active Expired - Lifetime
- 2005-12-09 EP EP05818366A patent/EP1843746B1/en not_active Expired - Lifetime
- 2005-12-09 KR KR1020077018617A patent/KR100983746B1/ko not_active Expired - Lifetime
- 2005-12-09 WO PCT/GB2005/004748 patent/WO2006075124A1/en not_active Ceased
- 2005-12-09 JP JP2007550826A patent/JP5171262B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP5171262B2 (ja)	2013-03-27
CA2594711C (en)	2012-11-06
AU2005324794B2 (en)	2010-05-13
KR20070104599A (ko)	2007-10-26
CA2594711A1 (en)	2006-07-20
JP2008526933A (ja)	2008-07-24
AU2005324794A1 (en)	2006-07-20
KR100983746B1 (ko)	2010-09-24
EP1843746A1 (en)	2007-10-17
AU2005324794C1 (en)	2010-12-02
WO2006075124A1 (en)	2006-07-20
EP1843746B1 (en)	2011-03-16

Publication	Publication Date	Title
PL1843746T3 (pl)	2011-09-30	Formulacje analogów somatostatyny
PL1888031T3 (pl)	2013-04-30	Preparaty analogu glp-1
GB2424581B (en)	2007-10-10	Formulations
PL1845942T3 (pl)	2014-07-31	Preparaty analogu GnRH
ZA200707654B (en)	2008-06-25	Formulations
EP1909584A4 (en)	2010-07-07	PRENYLFLAVONOID FORMULATIONS
GB0526419D0 (en)	2006-02-08	Formulation
EP1951693A4 (en)	2012-05-30	SOLID FORMULATIONS
GB0517673D0 (en)	2005-10-05	Formulation
IL187732A0 (en)	2008-08-07	Levodopa compositions
GB0501030D0 (en)	2005-02-23	Formulation
LT1928232T (lt)	2016-09-26	Kieta kompozicija
IL179208A0 (en)	2007-03-08	Intereferon formulations
GB0523634D0 (en)	2005-12-28	Solid cleaning formulations
PL115561U1 (en)	2007-01-22	Spatula
GB0522917D0 (en)	2005-12-21	Formulations
GB0526322D0 (en)	2006-02-01	Formulations
GB0518878D0 (en)	2005-10-26	Formulations
GB0520388D0 (en)	2005-11-16	Formulations
GB0519090D0 (en)	2005-10-26	Novel formulations
GB0504106D0 (en)	2005-04-06	Novel formulations
GB0500917D0 (en)	2005-02-23	Novel formulations
GB0500915D0 (en)	2005-02-23	Novel formulations
GB0500913D0 (en)	2005-02-23	Novel formulations
GB0500912D0 (en)	2005-02-23	Novel formulations